Neil Unmack

Resistant to strain

Novo Nordisk premium will survive drug wars

Get out of fail free

ECB's MPS kid gloves are a necessary evil

Darling buds of May

Assault on UK privilege has many possible targets

Gallic hug

French foray into Italian mobile will be hard slog

Brexit music

Italy first to exploit EU's new-found weakness

Io Brexit

Italy best to avoid sneaky bank bailout

Brexit hokey-kokey

How Europe can contain damage from Brexit

Kicking the kicking of the can

Greek deal is rational, predictable, messy

Far from prostrate

Sanofi bidding war looks expensive from the start

MDA comedown

CoCos can work, but the fix will be painful

Credit where it isn't due

When Mario Draghi buys, it's time to sell

Game of armchairs

Berlusconi, Bollore, Murdoch lock horns: who wins?

Still in Saipem

Italy ends up on wrong side of oil punt

High noon for high yield

Safe havens scarce in brewing high-yield storm

Half Marks

More Carney sounds better for BoE than for him

Selective binge

AstraZeneca's M&A flurry clears value hurdle

Dismantling Europe

Europe's least bad option: ditch Schengen

Your pain my gain

Mediobanca gets Barclays to pay for its own pivot

Political Viagra

Pfizer-Allergan gets no support from scaredy arbs

Betting on Bollore

Bollore's tilt at Telecom Italia board is too cheeky